Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice

Nature volume 464, pages 409–412 (2010)Cite this article

Subjects

Abstract

Sequence polymorphisms in a 58-kilobase (kb) interval on chromosome 9p21 confer a markedly increased risk of coronary artery disease (CAD), the leading cause of death worldwide1,2. The variants have a substantial effect on the epidemiology of CAD and other life-threatening vascular conditions because nearly one-quarter of Caucasians are homozygous for risk alleles. However, the risk interval is devoid of protein-coding genes and the mechanism linking the region to CAD risk has remained enigmatic. Here we show that deletion of the orthologous 70-kb non-coding interval on mouse chromosome 4 affects cardiac expression of neighbouring genes, as well as proliferation properties of vascular cells. Chr4Δ70kb/Δ70kb mice are viable, but show increased mortality both during development and as adults. Cardiac expression of two genes near the non-coding interval, Cdkn2a and Cdkn2b, is severely reduced in chr4Δ70kb/Δ70kb mice, indicating that distant-acting gene regulatory functions are located in the non-coding CAD risk interval. Allele-specific expression of Cdkn2b transcripts in heterozygous mice showed that the deletion affects expression through a cis-acting mechanism. Primary cultures of chr4Δ70kb/Δ70kb aortic smooth muscle cells exhibited excessive proliferation and diminished senescence, a cellular phenotype consistent with accelerated CAD pathogenesis. Taken together, our results provide direct evidence that the CAD risk interval has a pivotal role in regulation of cardiac Cdkn2a/b expression, and suggest that this region affects CAD progression by altering the dynamics of vascular cell proliferation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Deletion of the non-coding region orthologous to the 58-kb CAD risk interval on human chromosome 9p21.
Figure 2: Deletion of the CAD risk interval affects expression of neighbouring genes Cdkn2a and Cdkn2b.
Figure 3: Deletion of the CAD risk interval affects gene expression through a cis -regulatory mechanism.
Figure 4: Deletion of the CAD risk interval disrupts normal dynamics of cellular proliferation and senescence.

Similar content being viewed by others

References

  1. Helgadottir, A. et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491–1493 (2007)

    Article  ADS  CAS  Google Scholar 

  2. McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488–1491 (2007)

    Article  ADS  CAS  Google Scholar 

  3. Lloyd-Jones, D. et al. Heart disease and stroke statistics—2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, e21–e181 (2009)

    PubMed  Google Scholar 

  4. Topol, E. J., Smith, J., Plow, E. F. & Wang, Q. K. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum. Mol. Genet. 15, R117–R123 (2006)

    Article  CAS  Google Scholar 

  5. Schunkert, H. et al. Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 117, 1675–1684 (2008)

    Article  Google Scholar 

  6. Hinohara, K. et al. Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations. J. Hum. Genet. 53, 357–359 (2008)

    Article  Google Scholar 

  7. Lemmens, R. et al. Variant on 9p21 strongly associates with coronary heart disease, but lacks association with common stroke. Eur. J Hum. Genet. 17, 1287–1293 (2009)

    Article  CAS  Google Scholar 

  8. Shen, G. Q. et al. Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J. Hum. Genet. 53, 144–150 (2008)

    Article  Google Scholar 

  9. Zhou, L. et al. Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arterioscler. Thromb. Vasc. Biol. 28, 2085–2089 (2008)

    Article  CAS  Google Scholar 

  10. Helgadottir, A. et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nature Genet. 40, 217–224 (2008)

    Article  CAS  Google Scholar 

  11. Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223–227 (2009)

    Article  ADS  CAS  Google Scholar 

  12. Pasmant, E. et al. Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense non-coding RNA whose expression coclusters with ARF. Cancer Res. 67, 3963–3969 (2007)

    Article  CAS  Google Scholar 

  13. Jarinova, O. et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler. Thromb. Vasc. Biol. 29, 1671–1677 (2009)

    Article  CAS  Google Scholar 

  14. Liu, Y. et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One 4, e5027 (2009)

    Article  ADS  Google Scholar 

  15. Karolchik, D. et al. The UCSC Genome Browser Database: 2008 update. Nucleic Acids Res. 36, D773–D779 (2008)

    Article  CAS  Google Scholar 

  16. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996)

    Article  CAS  Google Scholar 

  17. Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649–659 (1997)

    Article  CAS  Google Scholar 

  18. Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H. & DePinho, R. A. The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis. Oncogene 23, 379–385 (2004)

    Article  CAS  Google Scholar 

  19. Latres, E. et al. Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19, 3496–3506 (2000)

    Article  CAS  Google Scholar 

  20. Besson, A., Assoian, R. K. & Roberts, J. M. Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nature Rev. Cancer 4, 948–955 (2004)

    Article  CAS  Google Scholar 

  21. Paigen, B., Morrow, A., Brandon, C., Mitchell, D. & Holmes, P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57, 65–73 (1985)

    Article  CAS  Google Scholar 

  22. Plump, A. S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353 (1992)

    Article  CAS  Google Scholar 

  23. Zhang, S. H., Reddick, R. L., Piedrahita, J. A. & Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468–471 (1992)

    Article  ADS  CAS  Google Scholar 

  24. Broadbent, H. M. et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum. Mol. Genet. 17, 806–814 (2008)

    Article  CAS  Google Scholar 

  25. Gizard, F. et al. PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a. J. Clin. Invest. 115, 3228–3238 (2005)

    Article  CAS  Google Scholar 

  26. Diéz-Juan, A. & Andres, V. The growth suppressor p27Kip1 protects against diet-induced atherosclerosis. FASEB J. 15, 1989–1995 (2001)

    Article  Google Scholar 

  27. González, P. et al. A single-nucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the risk of myocardial infarction. BMC Biol. 2, 5 (2004)

    Article  Google Scholar 

  28. Rodríguez, I. et al. Role of the CDKN1A/p21, CDKN1C/p57, and CDKN2A/p16 genes in the risk of atherosclerosis and myocardial infarction. Cell Cycle 6, 620–625 (2007)

    Article  Google Scholar 

  29. Yoshida, T., Kaestner, K. H. & Owens, G. K. Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ. Res. 102, 1548–1557 (2008)

    Article  CAS  Google Scholar 

  30. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo.. Proc. Natl Acad. Sci. USA 92, 9363–9367 (1995)

    Article  ADS  CAS  Google Scholar 

  31. Ueda, Y. et al. Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J. Biol. Chem. 275, 20368–20373 (2000)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank G. Owens for critical suggestions and discussion, T. Ley for providing vector pTURBO-Cre, and D. Lee for help with plasma lipid analysis. L.A.P., E.M.R. and J.C.C. were supported by the National Heart, Lung, and Blood Institute, D.M. and C.A. by EMBO long-term fellowships and L.A.P. by the National Human Genome Research Institute. Research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California. Plasma lipid analysis at the University of Cincinnati Mouse Metabolic Phenotyping Center was supported by MMPC DK59630. All animal work was reviewed and approved by the LBNL Animal Welfare and Research Committee.

Author Contributions A.V. and L.A.P. wrote the manuscript. All authors contributed to data collection and analysis and provided comments on the manuscript.

Author information

Authors and Affiliations

  1. Genomics Division, MS 84-171, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA,

    Axel Visel, Yiwen Zhu, Dalit May, Veena Afzal, Elaine Gong, Catia Attanasio, Matthew J. Blow, Edward M. Rubin & Len A. Pennacchio

  2. US Department of Energy Joint Genome Institute, Walnut Creek, California 94598, USA,

    Axel Visel, Matthew J. Blow, Edward M. Rubin & Len A. Pennacchio

  3. Department of Molecular Genetics, Department of Internal Medicine, and Center for Human Nutrition, UT Southwestern Medical Center at Dallas, Dallas, Texas 75390, USA,

    Jonathan C. Cohen

Authors
  1. Axel Visel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yiwen Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dalit May
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Veena Afzal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elaine Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Catia Attanasio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Matthew J. Blow
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jonathan C. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Edward M. Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Len A. Pennacchio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Len A. Pennacchio.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

This file contains Supplementary Text, Supplementary Figures 1- 9 with Legends, Supplementary Tables 1- 4 and Supplementary References. (PDF 1484 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Visel, A., Zhu, Y., May, D. et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464, 409–412 (2010). https://doi.org/10.1038/nature08801

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature08801

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research